Fatigue as a Driver of Overall Quality of Life in Cancer Patients
- PMID: 26070133
- PMCID: PMC4466533
- DOI: 10.1371/journal.pone.0130023
Fatigue as a Driver of Overall Quality of Life in Cancer Patients
Abstract
Background: This manuscript describes an approach for analyzing large amounts of disparate clinical data to elucidate the most impactful factor(s) that relate to a meaningful clinical outcome, in this case, the quality of life of cancer patients. The relationships between clinical and quality of life variables were evaluated using the EORTC QLQ-C30 global health domain--a validated surrogate variable for overall cancer patient well-being.
Methods: A cross-sectional study design was used to evaluate the determinants of global health in cancer patients who initiated treatment at two regional medical centers between January 2001 and December 2009. Variables analyzed included 15 EORTC QLQ-C30 scales, age at diagnosis, gender, newly diagnosed/ recurrent disease status, and stage. The decision tree algorithm, perhaps unfamiliar to practicing clinicians, evaluates the relative contribution of individual parameters in classifying a clinically meaningful functional endpoint, such as the global health of a patient.
Findings: Multiple patient characteristics were identified as important contributors. Fatigue, in particular, emerged as the most prevalent indicator of cancer patients' quality of life in 16/23 clinically relevant subsets. This analysis allowed results to be stated in a clinically-intuitive, rule set format using the language and quantities of the Quality of Life (QoL) tool itself.
Interpretation: By applying the classification algorithms to a large data set, identification of fatigue as a root factor in driving global health and overall QoL was revealed. The ability to practice mining of clinical data sets to uncover critical clinical insights that are immediately applicable to patient care practices is illustrated.
Conflict of interest statement
Figures



Similar articles
-
Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.Oncology. 2008;74 Suppl 1:7-12. doi: 10.1159/000143212. Epub 2008 Aug 28. Oncology. 2008. PMID: 18758191
-
Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.Am J Gastroenterol. 2005 Apr;100(4):918-26. doi: 10.1111/j.1572-0241.2005.40859.x. Am J Gastroenterol. 2005. PMID: 15784041
-
Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.Asia Pac J Clin Oncol. 2014 Jun;10(2):109-17. doi: 10.1111/ajco.12070. Epub 2013 Apr 1. Asia Pac J Clin Oncol. 2014. PMID: 23551530
-
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.J Clin Oncol. 1999 Sep;17(9):2932-40. doi: 10.1200/JCO.1999.17.9.2932. J Clin Oncol. 1999. PMID: 10561373
-
The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.Eur J Oncol Nurs. 2014 Aug;18(4):425-35. doi: 10.1016/j.ejon.2014.03.005. Epub 2014 Apr 8. Eur J Oncol Nurs. 2014. PMID: 24721179 Clinical Trial.
Cited by
-
Epigenomic Links Between Social Determinants of Health and Symptoms: A Scoping Review.Biol Res Nurs. 2023 Jul;25(3):404-416. doi: 10.1177/10998004221147300. Epub 2022 Dec 20. Biol Res Nurs. 2023. PMID: 36537264 Free PMC article.
-
Patient-centered outcomes and preference between darolutamide and enzalutamide: insights from the ODENZA trial.Transl Androl Urol. 2025 May 30;14(5):1160-1164. doi: 10.21037/tau-2024-755. Epub 2025 May 27. Transl Androl Urol. 2025. PMID: 40529039 Free PMC article. No abstract available.
-
Inflammatory Biomarkers, Hematopoietic Stem Cells, and Symptoms in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy.JNCI Cancer Spectr. 2020 May 8;4(5):pkaa037. doi: 10.1093/jncics/pkaa037. eCollection 2020 Oct. JNCI Cancer Spectr. 2020. PMID: 33134822 Free PMC article.
-
Factors associated with reduction in quality of life after SARS-CoV-2 infection.Sci Rep. 2025 Feb 26;15(1):6833. doi: 10.1038/s41598-025-91388-z. Sci Rep. 2025. PMID: 40000883 Free PMC article.
-
Fatigue in Prostate Cancer: A Roundtable Discussion and Thematic Literature Review.Eur Urol Open Sci. 2024 Apr 4;63:119-125. doi: 10.1016/j.euros.2024.03.003. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38596782 Free PMC article. Review.
References
-
- Qi Y, Schild SE, Mandrekar SJ, Tan AD, Krook JE, Rowland KM, et al. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2009;4: 1075–1082. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954489&tool=p... - PMC - PubMed
-
- Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. Elsevier Ltd; 2009;10: 865–871. Available: http://www.ncbi.nlm.nih.gov/pubmed/19695956 10.1016/S1470-2045(09)70200-1 - DOI - PubMed
-
- Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the Significance of Changes in Health-Related Quality of Life Scores. Journal of Clinical Oncology. 1998. pp. 139–144. - PubMed
-
- Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29: 89–96. Available: http://www.ncbi.nlm.nih.gov/pubmed/21098316 10.1200/JCO.2010.28.0107 - DOI - PubMed
-
- Levin RD, Daehler MA, Grutsch JF, Quiton J, Lis CG, Peterson C, et al. Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer. Nature Publishing Group; 2005;93: 1202–1208. Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=... - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical